ZOLI, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 5.029
AS - Asia 3.241
EU - Europa 1.542
SA - Sud America 594
Continente sconosciuto - Info sul continente non disponibili 170
AF - Africa 100
OC - Oceania 56
Totale 10.732
Nazione #
US - Stati Uniti d'America 4.842
SG - Singapore 1.075
CN - Cina 859
IT - Italia 627
BR - Brasile 467
VN - Vietnam 332
HK - Hong Kong 309
DE - Germania 190
TR - Turchia 183
UA - Ucraina 141
BD - Bangladesh 133
GB - Regno Unito 126
FR - Francia 90
CA - Canada 87
RU - Federazione Russa 82
IN - India 72
MX - Messico 66
ID - Indonesia 55
AU - Australia 54
FI - Finlandia 52
PL - Polonia 50
AR - Argentina 45
NL - Olanda 44
ZA - Sudafrica 40
JP - Giappone 39
SE - Svezia 31
IQ - Iraq 27
ES - Italia 21
EC - Ecuador 20
IR - Iran 19
PH - Filippine 17
CO - Colombia 15
MA - Marocco 15
PK - Pakistan 15
MY - Malesia 13
CL - Cile 12
CZ - Repubblica Ceca 12
UZ - Uzbekistan 12
VE - Venezuela 12
AT - Austria 11
LT - Lituania 11
NG - Nigeria 11
PY - Paraguay 11
SA - Arabia Saudita 10
IE - Irlanda 9
TW - Taiwan 9
EG - Egitto 7
JM - Giamaica 7
JO - Giordania 7
TH - Thailandia 7
CH - Svizzera 6
GR - Grecia 6
NI - Nicaragua 6
PE - Perù 6
TN - Tunisia 6
BE - Belgio 5
HU - Ungheria 5
KE - Kenya 5
KZ - Kazakistan 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CR - Costa Rica 4
DZ - Algeria 4
HN - Honduras 4
KG - Kirghizistan 4
KR - Corea 4
LB - Libano 4
PT - Portogallo 4
RS - Serbia 4
AF - Afghanistan, Repubblica islamica di 3
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
NP - Nepal 3
PS - Palestinian Territory 3
RO - Romania 3
TT - Trinidad e Tobago 3
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
BW - Botswana 2
CU - Cuba 2
DK - Danimarca 2
ET - Etiopia 2
GE - Georgia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
NZ - Nuova Zelanda 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BS - Bahamas 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
Totale 10.554
Città #
Ashburn 774
Singapore 700
Fairfield 479
Santa Clara 385
San Jose 358
Hong Kong 304
Beijing 282
Woodbridge 211
Council Bluffs 205
Seattle 203
Wilmington 168
Cambridge 158
Izmir 157
Houston 156
Ho Chi Minh City 133
New York 95
Nanjing 78
Dallas 72
Los Angeles 72
Milan 71
Princeton 69
Hanoi 68
Lauterbourg 68
Ann Arbor 63
Jacksonville 57
Munich 54
Boardman 53
São Paulo 53
Rome 49
Mexico City 46
Bologna 43
Warsaw 40
Helsinki 34
Jakarta 34
London 33
Shanghai 32
Tokyo 32
Toronto 31
Chicago 29
San Diego 28
Sydney 28
Shenyang 26
Ferrara 25
Chandler 23
Atlanta 22
Florence 22
Bremen 20
Brooklyn 18
Buffalo 18
Nanchang 18
Orem 18
Tianjin 18
Hebei 17
Jinan 17
Montreal 17
Turin 16
Guangzhou 15
Johannesburg 15
Melbourne 15
Phoenix 15
Turku 15
Verona 15
Denver 14
Frankfurt am Main 14
Rio de Janeiro 14
Baghdad 13
Belo Horizonte 13
Changsha 13
Chennai 13
Haiphong 13
Imola 13
Jiaxing 13
Modena 13
Da Nang 12
Norwalk 12
Stockholm 11
Istanbul 10
Moscow 10
Nuremberg 10
Palermo 10
San Francisco 10
Bari 9
Durham 9
Falls Church 9
Manchester 9
Mumbai 9
Ottawa 9
Porto Alegre 9
Brasília 8
Brno 8
Bắc Ninh 8
Dhaka 8
Fortaleza 8
Mountain View 8
Quito 8
Reggio Nell'emilia 8
Taizhou 8
Tampa 8
Zhengzhou 8
Amsterdam 7
Totale 6.779
Nome #
Effects of Ethanol on the Digestive System: A Narrative Review 450
Sindrome di Budd-Chiari a decorso fatale in paziente con policitemia vera e sindrome da anticorpi antifosfolipidi [Sindrome di Budd-Chiari a decorso fatale in paziente con policitemia vera e sindrome da anticorpi antifosfolipidi] 303
Alcohol Hub: il trattamento farmacologico dei disordini da uso di alcol 298
Sindrome da astinenza protratta da alcol: il ruolo del sodio ossibato...e non solo 259
Splenic autotransplantation after splenectomy: Tuftsin activity correlates with residual splenic function 209
Randomised controlled trial of mesalazine in IBS 207
A brief up-date of the use of sodium oxybate for the treatment of alcohol use disorder 205
Alcohol use disorder in the COVID-19 era: Position paper of the Italian Society on Alcohol (SIA) 200
Osteoporosis in Celiac Disease: An Update 193
Sodium oxybate in maintaining alcohol abstinence in alcoholic patients according to Lesch typologies: A pilot study 192
Nutritional Treatment in Crohn’s Disease 188
Cardiac involvement in Crohn's disease: Echocardiographic study 187
A controlled study of 20 mg famotidine nocte vs. 150 mg ranitidine nocte for the prevention of duodenal ulcer relapse 184
Effect of gluten-free diet on gut microbiota composition in patients with celiac disease and non-celiac gluten/wheat sensitivity 184
Beyond biologics: advanced therapies in inflammatory bowel diseases 172
Alcohol use disorders in the elderly: A brief overview from epidemiology to treatment options 169
Alcohol use in patients with chronic liver disease 168
Alcohol use disorder and GABAB receptor gene polymorphisms in an Italian sample: haplotype frequencies, linkage disequilibrium and association studies 166
Alcohol use disorders and liver fibrosis: an update 159
The course of inflammatory bowel disease during pregnancy and postpartum: A prospective European ECCO-EpiCom Study of 209 pregnant women 159
A reassessment of splenic hypofunction in celiac disease 155
Adalimumab for a co-existing clinical condition of Crohn's disease and acrodermatitis continua of Hallopeau 152
An evaluation of factors affecting helicobacter pylori prevalence in tibetans exiled in india 152
Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA) 152
Life-threatening onset of coeliac disease: A case report and literature review 146
Symptoms of protracted alcohol withdrawal in patients with alcohol use disorder: a comprehensive systematic review 142
Impaired splenic function and tuftsin deficiency in patients with intestinal failure on long term intravenous nutrition 142
Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology (SIGE) 142
Sodium oxybate plus nalmefene for the treatment of alcohol use disorder: A case series 142
Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity 141
Recurrent myocarditis in a patient with active ulcerative colitis: A case report and review of the literature 141
Gastrointestinal involvement in anderson-fabry disease: A narrative review 139
Impact of Female Gender in Inflammatory Bowel Diseases: A Narrative Review 138
Evidence-based decision for pharmacological management of alcoholic liver disease and alcohol dependence 137
Osteoporosis and Celiac Disease: Updates and Hidden Pitfalls 135
Prevalence of celiac disease in inflammatory bowel diseases: An IG-IBD multicentre study 131
CLINICAL APPLICATIONS OF SCANNING ELECTRON MICROSCOPY IN GASTROINTESTINAL DISEASES 130
Efficacy and safety of capsule endoscopy in octogenarian patients: a retrospective study 129
Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: A review 129
Plasma Norepinephrine, Weak Neurotransmitters, and Renin Activity During Active Tilting in Liver Cirrhosis: Relationship with Cardiovascular Homeostasis and Renal Function 128
Mortality risk in a cohort of Italian alcoholic individuals treated for alcohol dependence 128
Treatment of alcohol-use disorders 125
Promotion of gallbladder emptying by intravenous aminoacids 124
A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease 123
Therapeutic options for coeliac disease: What else beyond gluten-free diet? 122
Treatment of narcolepsy with cataplexy 120
Changes in peripheral blood lymphocytes and immune complexes in splenectomized patients: lack of correlation with residual splenic function 119
Cytophilic antibodies cause leucocyte migration inhibition in coeliac disease 119
Subclinical coeliac disease: an anthropometric assessment 118
Defective phagocyte activity in adult coeliac disease 115
Il trattamento farmacologico della dipendenza da alcol 115
Increased resting lipid oxidation in Crohn's disease 112
Gamma hydroxybutyric acid (GHB): A valid pharmacological opportunity for the treatment of alcohol dependence 111
Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: An open comparative study 108
Impaired tuftsin activity in cirrhosis: Relationship with splenic function and clinical outcome 107
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis 106
Use of pyridoxine-alpha-ketoglutarate (PAK) in hepatic encephalopathy 101
Alcohol Use in Adults Reply 101
Major gastrointestinal hemorrhage during anticoagulant therapy in patients with atrial fibrillation: When should treatment be resumed? [Emorragia gastrointestinale maggiore in corso di terapia anticoagulante nei pazienti con fibrillazione atriale: quando riprendere il trattamento? ] 98
Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn's disease: Partial benefit by infiximab - A pilot study 96
Increased energy expenditure in growing adolescents with Crohn's disease 96
Echocardiographic evaluation of anti-Tumor Necrosis Factor-α therapy with infliximab in patients without cardiac pathologies 95
Identification of harmful drinking in subjects who have had their driving license suspended due to alcohol use: a retrospective Italian study 94
Effect of arginine thiazolidinecarboxylate (ATCA)* * SULFILE is the trade name for arginine thiazolidinecarboxylate (200 mg vials) manufactured by Poli-Industria Chimica, Italy. on some clinical and functional parameters in cirrhotic patients 93
Tuftsin deficiency in AIDS 89
Ocular naevus and hyperaemia with dilation of the conjunctival vessels: An early manifestation of Crohn's disease? 87
S.E.M. study I: Gastric and duodenal lesions induced by non-steroidal anti-inflammatory drugs (aspirin, piroxicam) in man 83
Ultrastructural aspects of duodenal mucosa repair during treatment of peptic disease 82
Increased risk of breast cancer in first-degree relatives of Crohn's disease patients. An IG-IBD study 81
Howell‐Jolly body counting as a measure of splenic function. A reassessment 80
Failure of adrenergic system in the control of arterial pressure in cirrhosis. Role of weak neurotransmitters 79
S.E.M. study II. Protective effect of ranitidine against gastric and duodenal lesions induced by non-steroidal anti-inflammatory drugs 79
Pseudothrombocytopenia clinical comment on 37 cases 78
Efficacy and safety of gamma-hydroxybutyrate in treating alcohol withdrawal syndrome in an alcohol-dependent inpatient with decompensated liver cirrhosis: A case report 78
Famotidine vs ranitidine h.s. in acute duodenal ulcer. A multicentre endoscopic trial 76
Famotidine and ranitidine in the prevention of duodenal ulcer 70
The recognition and management of protracted alcohol withdrawal may improve and modulate the pharmacological treatment of alcohol use disorder 69
Totale 10.732
Categoria #
all - tutte 60.936
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.550
Totale 62.486


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022349 0 0 4 24 10 30 24 34 16 73 18 116
2022/2023267 73 9 20 4 26 15 18 15 36 1 34 16
2023/2024387 10 19 10 18 26 15 6 15 10 17 44 197
2024/20251.774 57 92 170 97 210 207 37 68 185 321 172 158
2025/20264.802 372 223 464 663 702 266 466 318 392 499 233 204
2026/2027797 297 343 157 0 0 0 0 0 0 0 0 0
Totale 10.732